IDI |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.8 EUR | -1.04% |
|
+1.07% | +12.46% |
| Apr. 09 | IDI: acquisition of a majority stake in Exsto | CF |
| Apr. 08 | IDI acquired an unknown majority stake in EXSTO SAS. | CI |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Its low valuation, with P/E ratio at 7.49 and 7.1 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company's "enterprise value to sales" ratio is among the highest in the world.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +12.46% | 594M | - | ||
| +19.72% | 38.2B | B | ||
| +3.71% | 36.64B | B | ||
| 0.00% | 19.89B | - | - | |
| +4.13% | 5.37B | - | C | |
| +4.79% | 3.3B | - | B- | |
| +19.40% | 2.85B | C- | ||
| +8.54% | 2.82B | D+ | ||
| -15.83% | 2.37B | C+ | ||
| +4.52% | 1.24B | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- IDIP Stock
- Ratings IDI
